Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
Abstract Despite the advancement of targeted therapy for pulmonary arterial hypertension (PAH), poor prognosis remains a reality. Mesenchymal stem cells (MSCs) are one of the most clinically feasible alternative treatment options. We compared the treatment effects of adipose tissue (AD)-, bone marro...
Guardado en:
Autores principales: | Seyeon Oh, Albert Y. Jang, Sehyun Chae, Seungbum Choi, Jeongsik Moon, Minsu Kim, Edda Spiekerkoetter, Roham T. Zamanian, Phillip C. Yang, Daehee Hwang, Kyunghee Byun, Wook-Jin Chung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d62962afa54f456283ebd67e47698adb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey
por: Christopher A. Thomas, et al.
Publicado: (2021) - Advances in pulmonary hypertension official journal of the Pulmonary Hypertension Association.
-
Multimodal fusion with deep neural networks for leveraging CT imaging and electronic health record: a case-study in pulmonary embolism detection
por: Shih-Cheng Huang, et al.
Publicado: (2020) -
Pulmonary Hypertension in the Dog
por: Poser Helen, et al.
Publicado: (2016) -
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
por: Robert P. Frantz, et al.
Publicado: (2021)